Evidence map›Paper›PMID 35440545›Full record

ArticleNature communications2022

Distinct and additive effects of calorie restriction and rapamycin in aging skeletal muscle.

Daniel J Ham, Anastasiya Börsch, Kathrin Chojnowska, Shuo Lin, Aurel B Leuchtmann, Alexander S Ham, Marco Thürkauf, Julien Delezie, Regula Furrer, Dominik Burri and 6 more

Erratum issuedOpen access · goldAbstract read
In one paragraph

Article in Nature communications, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 69 papers.

0numbers the graph read from it
0cells of the map it votes in
69citing papers in PubMed
7.5field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

69 citing papers in PubMed, 90 citations in OpenAlex.

  1. Trial
  2. Article
  3. Review
  4. Review
  5. Review
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Review
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Review

9 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

16 authors at 1 institution in 1 country.

Daniel J Ham *Biozentrum, University of Basel, Basel, Switzerland. dan.ham@unibas.ch.ORCID http://orcid.org/0000-0002-4552-8373
Anastasiya Börsch *Biozentrum, University of Basel, Basel, Switzerland.
Kathrin ChojnowskaBiozentrum, University of Basel, Basel, Switzerland.
Shuo LinBiozentrum, University of Basel, Basel, Switzerland.
Aurel B LeuchtmannBiozentrum, University of Basel, Basel, Switzerland.ORCID http://orcid.org/0000-0002-5800-005X
Alexander S HamBiozentrum, University of Basel, Basel, Switzerland.
Marco ThürkaufBiozentrum, University of Basel, Basel, Switzerland.
Julien DelezieBiozentrum, University of Basel, Basel, Switzerland.
Regula FurrerBiozentrum, University of Basel, Basel, Switzerland.
Dominik BurriBiozentrum, University of Basel, Basel, Switzerland.ORCID http://orcid.org/0000-0002-8131-9309
Michael SinnreichDepartment of Biomedicine, Pharmazentrum, University of Basel, Basel, Switzerland.
Christoph HandschinBiozentrum, University of Basel, Basel, Switzerland.ORCID http://orcid.org/0000-0003-0603-1097
Lionel A TintignacDepartment of Biomedicine, Pharmazentrum, University of Basel, Basel, Switzerland.
Mihaela Zavolan *Biozentrum, University of Basel, Basel, Switzerland.ORCID http://orcid.org/0000-0002-8832-2041
Nitish Mittal *Biozentrum, University of Basel, Basel, Switzerland. nitish.mittal@unibas.ch.ORCID http://orcid.org/0000-0002-1375-1503
Markus A Rüegg *Biozentrum, University of Basel, Basel, Switzerland. markus-a.ruegg@unibas.ch.ORCID http://orcid.org/0000-0002-4974-9384
University of Basel · CH

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Preserving skeletal muscle function is essential to maintain life quality at high age. Calorie restriction (CR) potently extends health and lifespan, but is largely unachievable in humans, making "CR mimetics" of great interest. CR targets nutrient-sensing pathways centering on mTORC1. The mTORC1 inhibitor, rapamycin, is considered a potential CR mimetic and is proven to counteract age-related muscle loss. Therefore, we tested whether rapamycin acts via similar mechanisms as CR to slow muscle aging. Here we show that long-term CR and rapamycin unexpectedly display distinct gene expression profiles in geriatric mouse skeletal muscle, despite both benefiting aging muscles. Furthermore, CR improves muscle integrity in mice with nutrient-insensitive, sustained muscle mTORC1 activity and rapamycin provides additive benefits to CR in naturally aging mouse muscles. We conclude that rapamycin and CR exert distinct, compounding effects in aging skeletal muscle, thus opening the possibility of parallel interventions to counteract muscle aging.

Indexed as

Caloric RestrictionSirolimusAgingAnimalsMechanistic Target of Rapamycin Complex 1MiceMuscle, SkeletalMechanistic Target of Rapamycin Complex 1Sirolimus

Identifiers

PMID35440545
PMCPMC9018781
OpenAlexW4225592252

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.